Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 13:37 (589 d 22:47 ago) – Posting: # 19925
Views: 916

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

Activity
 Admin contact
21,077 posts in 4,395 threads, 1,469 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Sunday 13:25 CEST (Europe/Vienna)

Politicians use statistics like drunkards use lampposts:
not for illumination, but for support.    attributed to Hans Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5